Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases

Marine Drugs - Switzerland
doi 10.3390/md17120699
Full Text
Abstract

Available in full text

Categories
Drug Discovery
Date
Authors
Publisher

MDPI AG

Related search

Diagnosis and Treatment of Cardiovascular Diseases

American Journal of Public Health and the Nations Health
1958English

Possibilities of Fucoidan Utilization in the Development of Pharmaceutical Dosage Forms

Marine Drugs
Drug Discovery
2019English

A Pharmaceutical Formulation and Evaluation of a Cardiovascular Drug for Improving Pulmonary Arterial Hypertension

International Journal of Biology, Pharmacy and Allied Sciences
2018English

Emerging Applications of Nanomedicine for the Diagnosis and Treatment of Cardiovascular Diseases

Trends in Pharmacological Sciences
ToxicologyPharmacology
2010English

Pharmaceutical Evaluation of the Hospital Grade Preparation of Timolol Gel for Infantile Hemangioma

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2017English

Obesity as a Risk Factor for the Development of Cardiovascular Diseases

2019English

Pcv130 - Value of Implementation of Pharmaceutical Care for Cardiovascular Diseases in Lmics: A Hypothetical Simulation for Decision Making

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Molecular Biological Techniques for the Diagnosis of Infectious Diseases

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
1992English

Thrombosis Treatment: Development of Polymer Microcapsules Functionalized With Fucoidan to Target P-Selectin Overexpressed in Cardiovascular Diseases (Adv. Healthcare Mater. 4/2017)

Advanced healthcare materials
Biomedical EngineeringBiomaterialsPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy